FAQ :: Definium Therapeutics (MNMD)

What is Definium Therapeutics's stock symbol?: Our stock is traded on the NASDAQ under the symbol DFTX, effective Jan. 13th, 2026.
When was Definium Therapeutics incorporated?: We were incorporated in 2010 in British Columbia.
When did Definium Therapeutics become a public company?: We went public in February 2020 through a reverse takeover transaction and then uplisted to Nasdaq in April 2021.
Where is Definium Therapeutics located?: Definium Therapeutics
One World Trade Center
Suite 8500
New York, NY 10007
United States
When is Definium Therapeutics's fiscal year end?: December 31st
Who is Definium Therapeutics's transfer agent?: Computershare Investor Services
100 University Ave.
8th Floor, North Tower
Toronto, Ontario M5J2Y1
Canada
T: 1-800-564-6253 (toll free in Canada and US)
T: 514-982-7555 (international direct dial)
F: 1-888-453-0330
Who is Definium Therapeutics's independent auditor?: KPMG LLP
How can I view documents Definium Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?: You can view all SEC filings on the SEC Filings page.
How do I transfer units, warrants or stock, change the address on my account or replace a lost certificate?: You can view our Transfer Agent contact information on the Contacts page or further up on this FAQ page.
Does Definium Therapeutics pay dividends?: Definium Therapeutics does not pay a dividend on stock, and does not foresee doing so in the immediate future. Accordingly, Difinium Therapeutics does not offer a DRIP (Dividend Reinvestment Program).
Does Definium Therapeutics have a direct stock purchase plan?: Currently, shares are not available for purchase directly from Definium Therapeutics and we do not have a direct purchase program available.
What do I do if my address has changed?: If your shares are held in your name, you may contact Computer Investor Services. If your shares are held in Street name (by your broker), you must contact your broker to update your address.